Susquehanna International Group’s Curanex Pharmaceuticals CURX Stock Holding History

Susquehanna International Group’s Portfolio CURX Stock Details CURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.89K	Buy	+733	New	+$5.34K	﹤0.01%	13208

Other funds holding CURX

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Susquehanna International Group's CURX Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Curanex Pharmaceuticals (CURX) in Q2 2026: 733 shares worth $3.89K. The stake represents ﹤0.01% of the portfolio and ranks #13208 among its holdings.

11 funds tracked by Wall St. Rank hold CURX as of Q2 2026.

Susquehanna International Group held 733 shares of Curanex Pharmaceuticals worth $3.89K as of Q2 2026.
Curanex Pharmaceuticals was a new Susquehanna International Group position in Q2 2026.
Curanex Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13208 holding.
11 funds tracked by Wall St. Rank held Curanex Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.